GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

[1]  Gordon H Guyatt,et al.  GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. , 2013, Journal of clinical epidemiology.

[2]  Michael G Stewart.  Summarizing the evidence , 2012, The Laryngoscope.

[3]  Howard Balshem,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[4]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[5]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[6]  Xin Sun,et al.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.

[7]  Matthias Briel,et al.  Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. , 2010, JAMA.

[8]  Philipp Dahm,et al.  Evidence‐based urology in practice: when to believe a subgroup analysis? , 2010, BJU international.

[9]  Gerta Rücker,et al.  Bmc Medical Research Methodology Open Access Undue Reliance on I 2 in Assessing Heterogeneity May Mislead , 2022 .

[10]  Alan Bensoussan,et al.  Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis , 2007, The Lancet.

[11]  G. Guyatt,et al.  A systematic review of studies comparing health outcomes in Canada and the United States , 2007, Open medicine : a peer-reviewed, independent, open-access journal.

[12]  M. Zuber.  Use of Calcium or Calcium in Combination with Vitamin D Supplementation to Prevent Fractures and Bone Loss in People Aged 50 Years and Older : a Meta-Analysis , 2007 .

[13]  G. Guyatt,et al.  Meta‐analysis of flavonoids for the treatment of haemorrhoids , 2006, The British journal of surgery.

[14]  G. Guyatt,et al.  Vasopressin or epinephrine for out-of-hospital cardiac arrest. , 2006, Annals of emergency medicine.

[15]  M. Egger,et al.  Risk of cardiovascular events and rofecoxib: cumulative meta-analysis , 2004, The Lancet.

[16]  H. Sitter,et al.  A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. , 2004, The New England journal of medicine.

[17]  Jonathan J Deeks,et al.  Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes , 2002, Statistics in medicine.

[18]  Gordon H Guyatt,et al.  Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. , 2002, International journal of epidemiology.

[19]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.

[20]  C H Schmid,et al.  An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. , 1998, Statistics in medicine.

[21]  G H Guyatt,et al.  Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. , 1994, JAMA.